# The Human Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2024, Regulation 48: Amendment of regulation 46


After regulation 46(2) (labelling of investigational medicinal products) insert—
“(3) Paragraph (1) does not apply to a POC investigational medicinal product that is to be administered in its entirety immediately after manufacture.”.

---
Source: https://www.legislation.gov.uk/ukdsi/2024/9780348264579/regulation/48 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-modular-manufacture-and-point-of-care-regulations-2024/regulation-48
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

